Over the past twenty-five years or so, this course has become a renowned programme for physicians and scientists with an interest in the diagnosis and treatment of haematological cancers.

LEARNING OBJECTIVES

• Learn or reinforce knowledge on modern diagnostic tools in haemato-oncology
• Understand the molecular pathology of lymphoma
• Retain the salient clinical features of important lymphoma entities
• Discuss and weigh evidence favouring particular treatment options in haematological oncology
• Become aware of the most important “open questions” and “unmet needs” in the management of the main lymphoma entities

PARTICIPANTS’ PROFILE

The programme is designed for postgraduate medical doctors at any stage of clinical career who are interested in haematological oncology. A mix of experienced clinicians or pathologists etc., and oncology/haematology trainees is welcome. Scientists (PhD) are very welcome too, but they should be advised that the course will emphasise clinical aspects rather than basic biology.

CME ACCREDITATION

The event has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. 
The event is designated for a maximum of 12 European CME credits (ECMEC).
Through an agreement between UEMS and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.

REGISTRATION

Registration may be carried out online. Registrations will be processed on a first-come/first-served basis.
The registration fee of EUR 380 includes all lectures and workshop sessions, access to the event dedicated website, coffee breaks and lunches at the course venue and according to the programme. Registration does not include accommodation which should be booked separately.

For more information or to register: Lymphoma